Skip to content

Is HIV drug resistance in decline in Europe?

BHIVA: 60% increase in drug-resistant gonorrhoea amongst UK gay men last year, HIV-positive men disproportionately affected

Continuing 3TC therapy after viral rebound shows no benefit

16% of drug-naive entering GSK US studies already have resistance

Resistance testing may be useful for some with 'undetectable' viral loads

Final results confirm twice-daily boosted fosamprenavir is comparable to twice-daily Kaletra in treatment-naive

Take home messages from the 15th HIV Resistance Workshop

15th HIV Resistance Workshop: does low-level resistance matter?

15th HIV Resistance Workshop: resistance to Kaletra monotherapy